Larix AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Larix AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11191
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Larix A/S (Larix) is a contract research organization that offers services related to clinical trials assistance. The organization provides services such as statistics, data management, clinical research, pharmacovigilance and data monitoring among others. It offers services across all phases of clinical trials and assists from initiation and conduct to close-out and finalization. Larix caters to pharmaceutical, biotechnology and medical device companies. The organization therapeutic fields include endocrinology, cardiology, haematology, psychiatry, pain, reproductive health, immunology, oncology and infectious diseases, among others. It operates in Finland, Norway and Sweden. Larix is headquartered in Copenhagen, Denmark.

Larix AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Larix A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Larix A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Larix A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Larix A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Larix A/S, Medical Devices Deals, 2012 to YTD 2018 9
Larix A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Larix A/S, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Larix Acquires Projects of Norma 11
Partnerships 12
SpectraCure Enters into Agreement with Larix 12
Licensing Agreements 13
Larix Enters Into Licensing Agreement With Omnicomm For eClinical Solutions 13
Larix A/S – Key Competitors 14
Larix A/S – Key Employees 15
Larix A/S – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Larix A/S, Pharmaceuticals & Healthcare, Key Facts 2
Larix A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Larix A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Larix A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Larix A/S, Deals By Therapy Area, 2012 to YTD 2018 8
Larix A/S, Medical Devices Deals, 2012 to YTD 2018 9
Larix A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Larix Acquires Projects of Norma 11
SpectraCure Enters into Agreement with Larix 12
Larix Enters Into Licensing Agreement With Omnicomm For eClinical Solutions 13
Larix A/S, Key Competitors 14
Larix A/S, Key Employees 15
Larix A/S, Other Locations 16
Larix A/S, Subsidiaries 16

List of Figures
Larix A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Larix A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Larix A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Larix A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Larix A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Larix A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Larix A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Larix A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Larix A/S, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Larix AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carl Zeiss Meditec AG (AFX):医療機器:M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, is an integrated medical technology company, which provides visualization solutions for minimally invasive surgical treatments. It operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. T …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CSX Corporation, Inc.:戦略・SWOT・企業財務分析
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Turkiye Halk Bankasi AS:企業の戦略・SWOT・財務分析
    Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Halk Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Guthy-Renker LLC:企業の戦略的SWOT分析
    Guthy-Renker LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Panasonic Corporation:企業の戦略・SWOT・財務分析
    Panasonic Corporation - Strategy, SWOT and Corporate Finance Report Summary Panasonic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • InTouch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Pembina Pipeline Corp (PPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pembina Pipeline Corp (Pembina) is a midstream oil and gas company. It owns and operates an integrated system of pipelines that transports hydrocarbon liquids such as conventional crude oil, heavy oil, synthetic crude oil, and oil sands products. The company offers services such as oil and n …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Newfield Exploration Company:戦略・SWOT・企業財務分析
    Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report Summary Newfield Exploration Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ogeda SA-製薬・医療分野:企業M&A・提携分析
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA is a biotechnology company that develops small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treats hormone-dependent pathologies in women's health. It also develops drugs to treat neurodegenerativ …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company offers services such as consultancy services, administration, financing, development, and management of wind farms. It also offe …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Eni SpA (ENI):石油・ガス:M&Aディール及び事業提携情報
    Summary Eni SpA (Eni) is an integrated oil and gas company that carries out oil and natural gas exploration, field development and production activities. It is also involved in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company has operations in Italy, Cyprus, the U …
  • Bolsas y Mercados Espanoles SA (BME):企業の財務・戦略的SWOT分析
    Summary Bolsas y Mercados Espanoles SA (BME) is an investment service provider that operates financial system. The company is an operator of financial systems. It offers services, products and advanced trading and global market access systems to issuers, intermediaries and investors. BME also offers …
  • Inova Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include QUANTA Flash used for semi-quantitative determination of aut …
  • WInco Foods LLC:企業の戦略・SWOT・財務情報
    WInco Foods LLC - Strategy, SWOT and Corporate Finance Report Summary WInco Foods LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆